Evaluation of the response to treatment of solid tumours – a consensus statement of the International Cancer Imaging Society
on behalf of the Membership of the International Cancer Imaging SocietyAcademic Department of Diagnostic Radiology, Royal Marsden Hospital, Sutton, UKJanet E. HusbandMagnetic Resonance Imaging (MRI), Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Room C-276, New York, USALawrence H. SchwartzDepartment of Clinical Radiology, Lincoln Wing, St James' University Hospital, LEEDS, UKJohn SpencerDepartment of Clinical Radiology, Lincoln Wing, St James' University Hospital, Beckett Street, LEEDS, LS9 7TF, UKL. OllivierThe Royal Marsden NHS Trust, London, UKD M KingThe Royal Marsden NHS Trust, Fulham Road, London, SW3 6JJ, UKRoderick J. JohnsonAcademic Department of Diagnostic Radiology, St Bartholomew's Hospital, Dominion House, 59 Bartholomew Close, London, UKRodney H. ReznekAcademic Department of Diagnostic Radiology, St Bartholomew's Hospital, Dominion House, 59 Bartholomew Close, London, EC1A 7ED, UK
2004en
Ochiq kirishGibrid
Litsenziya: cc-by-nc-sa
ABI
Annotatsiya
New guidelines to evaluate the response to treatment in solid tumors using imaging techniques have major limitations and important implications for radiological workload. This consensus statement from the International Cancer Imaging Society (ICIS) reviews the RECIST criteria and addresses several challenges regarding tumour measurement. Recommendations are made regarding tumour measurement and other issues are raised. The growing need to introduce a multimodality approach to monitoring response is recognized. ICIS welcomes a dialogue with the authors of RECIST to address issues raised in this review.
Hali tarjima qilinmagan
Identifikatorlar
Iqtiboslar va manbalar
2 ta iqtibos0 ta foydalanilgan manba